Related Articles
In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells.
In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R
The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice
The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells
miR-181b promotes chemoresistance in breast cancer by regulating Bim expression